JPWO2020218465A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020218465A5
JPWO2020218465A5 JP2021516229A JP2021516229A JPWO2020218465A5 JP WO2020218465 A5 JPWO2020218465 A5 JP WO2020218465A5 JP 2021516229 A JP2021516229 A JP 2021516229A JP 2021516229 A JP2021516229 A JP 2021516229A JP WO2020218465 A5 JPWO2020218465 A5 JP WO2020218465A5
Authority
JP
Japan
Prior art keywords
subject
kit
abundance
endometriosis
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021516229A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020218465A1 (https=
JP7535270B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/017595 external-priority patent/WO2020218465A1/ja
Publication of JPWO2020218465A1 publication Critical patent/JPWO2020218465A1/ja
Publication of JPWO2020218465A5 publication Critical patent/JPWO2020218465A5/ja
Priority to JP2024119174A priority Critical patent/JP2024150669A/ja
Application granted granted Critical
Publication of JP7535270B2 publication Critical patent/JP7535270B2/ja
Priority to JP2026010934A priority patent/JP2026065204A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021516229A 2019-04-26 2020-04-24 子宮内膜症の診断方法、病態モニタリング方法及びキット Active JP7535270B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024119174A JP2024150669A (ja) 2019-04-26 2024-07-25 子宮内膜症の診断方法、病態モニタリング方法及びキット
JP2026010934A JP2026065204A (ja) 2019-04-26 2026-01-27 子宮内膜症の診断方法、病態モニタリング方法及びキット

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019086223 2019-04-26
JP2019086223 2019-04-26
PCT/JP2020/017595 WO2020218465A1 (ja) 2019-04-26 2020-04-24 子宮内膜症の診断方法、病態モニタリング方法及びキット

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024119174A Division JP2024150669A (ja) 2019-04-26 2024-07-25 子宮内膜症の診断方法、病態モニタリング方法及びキット

Publications (3)

Publication Number Publication Date
JPWO2020218465A1 JPWO2020218465A1 (https=) 2020-10-29
JPWO2020218465A5 true JPWO2020218465A5 (https=) 2024-01-04
JP7535270B2 JP7535270B2 (ja) 2024-08-16

Family

ID=72942212

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021516229A Active JP7535270B2 (ja) 2019-04-26 2020-04-24 子宮内膜症の診断方法、病態モニタリング方法及びキット
JP2024119174A Pending JP2024150669A (ja) 2019-04-26 2024-07-25 子宮内膜症の診断方法、病態モニタリング方法及びキット
JP2026010934A Pending JP2026065204A (ja) 2019-04-26 2026-01-27 子宮内膜症の診断方法、病態モニタリング方法及びキット

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024119174A Pending JP2024150669A (ja) 2019-04-26 2024-07-25 子宮内膜症の診断方法、病態モニタリング方法及びキット
JP2026010934A Pending JP2026065204A (ja) 2019-04-26 2026-01-27 子宮内膜症の診断方法、病態モニタリング方法及びキット

Country Status (5)

Country Link
US (1) US20220221472A1 (https=)
EP (1) EP3961217A4 (https=)
JP (3) JP7535270B2 (https=)
CN (1) CN113994208A (https=)
WO (1) WO2020218465A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021013783A1 (en) * 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a12 as blood biomarker for the non-invasive diagnosis of endometriosis
KR20220154725A (ko) * 2020-03-16 2022-11-22 프로테오믹스 인터내셔널 피티와이 리미티드 자궁내막증 바이오마커
CN113325183B (zh) * 2021-06-01 2022-11-15 中国医学科学院北京协和医院 一种用于鉴别诊断em/fem的试剂盒
WO2025026908A1 (en) * 2023-07-28 2025-02-06 Roche Diagnostics Gmbh Serum epha1 as biomarker for endometriosis
WO2025084848A1 (ko) * 2023-10-18 2025-04-24 주식회사 노브메타파마 Clic1을 이용한 섬유증 치료제의 스크리닝 방법
WO2025260122A1 (en) * 2024-06-19 2025-12-26 Proteomics International (Ip) Pty Ltd Biomarkers for endometriosis
GB202410764D0 (en) * 2024-07-23 2024-09-04 Univ Of Hull Diagnostic test
CN118995917A (zh) * 2024-09-30 2024-11-22 暨南大学 Ppif基因作为标志物在子宫内膜异位症诊断评估中的应用
CN121304682B (zh) * 2025-12-15 2026-03-31 西安市第一医院 基于图像处理的子宫内膜异位症病灶智能识别方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE374370T1 (de) * 1999-01-25 2007-10-15 Siemens Medical Solutions Diag Verfahren zur diagnose von endometriose
EP1290218B8 (en) * 2000-02-25 2007-10-03 Siemens Medical Solutions Diagnostics Endometriosis-related markers and uses thereof
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
AU2003253440A1 (en) * 2002-08-30 2004-04-30 Japan As Represented By The President Of The University Of Tokyo Method of diagnosing ovarian endometriosis
JP5159619B2 (ja) 2005-06-22 2013-03-06 ザ・ジョンズ・ホプキンス・ユニバーシティ 卵巣癌のバイオマーカー：ｃｔａｐ３関連タンパク質
AR061571A1 (es) 2006-06-23 2008-09-03 Smithkline Beecham Corp Compuesto sal del acido toluenosulfonico de 4-{[6-cloro-3-({[(2- cloro-3-fluorofenil) amino]carbonil} amino)- 2- hidroxifenil]sulfonil] -1- piperazinacarbxilato de 1.1-dimetiletilo, composicion farmaceutica que lo comprende su uso para la fabricacion de un medicamento combinacion farmaceutica con un
US9404932B2 (en) * 2007-11-05 2016-08-02 Nordic Bioscience A/S Pathology biomarker assay
JP2009168646A (ja) * 2008-01-17 2009-07-30 Fuji Pharmaceutical Co Ltd 子宮内膜症に特異的なバイオマーカー
US20120315267A1 (en) 2010-02-09 2012-12-13 Glaxosmithkline Llc Novel uses
WO2012112434A1 (en) 2011-02-14 2012-08-23 Allergan, Inc. Inhibiting aberrant blood vessel formation using retargeted endopeptidases
WO2013178794A1 (en) * 2012-05-31 2013-12-05 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) A novel method for the diagnosis of endometriosis
WO2015050875A1 (en) * 2013-10-01 2015-04-09 The Regents Of The University Of California Endometriosis classifier
GB201403489D0 (en) * 2014-02-27 2014-04-16 Univ London Queen Mary Biomarkers for endometriosis
JPWO2015174544A1 (ja) 2014-05-16 2017-04-20 国立研究開発法人国立精神・神経医療研究センター 精神疾患判定マーカー
KR20170014561A (ko) * 2015-07-30 2017-02-08 한국과학기술연구원 Ｃｘｃｌ7 측정 제제를 포함하는 대장암 진단용 조성물, 키트, 및 이를 이용한 대장암 진단 방법

Similar Documents

Publication Publication Date Title
JPWO2020218465A5 (https=)
JP2020526747A5 (https=)
Grant et al. Proteomic analysis of a noninvasive human model of acute inflammation and its resolution: the twenty-one day gingivitis model
WO2005042761A3 (en) Biomarkers for amyotrophic lateral sclerosis
Devarajan Genomic and proteomic characterization of acute kidney injury
CN112946274B (zh) 颅内动脉瘤诊断血清标志物以及预测颅内动脉瘤破裂潜能血清标志物
JP2018529931A5 (https=)
CY1119797T1 (el) Λακτοφερινη για χρηση στη διαγνωση και προγνωση της νοσου alzheimer
Mohammed et al. Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower‐leg injury or knee arthroscopy
JP4765078B2 (ja) 病態を識別するための体液試料中に含まれるポリペプチドおよびマーカーの定量的評価のための装置および方法
JP2014521972A (ja) マクロファージ遊走阻止因子（ＭＩＦ）の血漿濃度の測定を含む急性冠動脈症候群（ＡＣＳ）の診断、予後診断（ｐｒｏｇｎｏｓｉｓ）又は治療の方法
JP6917722B2 (ja) 口腔の健康状態の評価方法
DE60025170D1 (de) Diagnostisches verfahren für asthma
JP4664280B2 (ja) 生体分子サンプルの特性を決定する方法
CN107589260A (zh) 尿液中mmp-7作为肾脏纤维化和慢性肾脏病的生物标志物的用途
Murphy et al. Dataset on the comparative proteomic profiling of mouse saliva and serum from wild type versus the dystrophic mdx-4cv mouse model of dystrophinopathy
Bossart et al. Protein electrophoresis of serum from healthy Atlantic bottlenose dolphins (Tursiops truncatus).
JP4735503B2 (ja) 腹膜機能マーカー、その分析方法およびその用途
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
JP2023156159A5 (https=)
CN114814225B (zh) Crabp2蛋白的应用
ARUMUGASAMY et al. Association of Diabetic Kidney Disease Markers and Urinary Beta-crossLaps in Type 2 Diabetes.
Martínez Advances in the study of inflammation biomarkers in the saliva of pig
Gawel et al. EVALUATION OF A QUANTITATIVE IMMUNOTURBIDIMETRIC D-DIMER ASSAY IN ADULT ASIAN (ELEPHAS MAXIMUS) AND AFRICAN (LOXODONTA AFRICANA) ELEPHANTS—PROOF OF CONCEPT
US20230333089A1 (en) Methods for determining the moisture content of the skin